nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Alkylating Activity—Temozolomide—malignant glioma	0.261	0.522	CiPCiCtD
Ifosfamide—germ cell cancer—malignant glioma	0.258	1	CtDrD
Ifosfamide—Alkylating Activity—Carmustine—malignant glioma	0.239	0.478	CiPCiCtD
Ifosfamide—CYP2C18—malignant glioma	0.085	0.448	CbGaD
Ifosfamide—CYP2B6—malignant glioma	0.0631	0.333	CbGaD
Ifosfamide—PTGS1—malignant glioma	0.0415	0.219	CbGaD
Ifosfamide—Lung fibrosis interstitial—Carmustine—malignant glioma	0.00176	0.0534	CcSEcCtD
Ifosfamide—Myelodysplastic syndrome—Temozolomide—malignant glioma	0.000978	0.0297	CcSEcCtD
Ifosfamide—Pulmonary toxicity—Carmustine—malignant glioma	0.000894	0.0271	CcSEcCtD
Ifosfamide—Status epilepticus—Temozolomide—malignant glioma	0.000833	0.0253	CcSEcCtD
Ifosfamide—Infertility—Carmustine—malignant glioma	0.000778	0.0236	CcSEcCtD
Ifosfamide—Cyclophosphamide—CYP2C18—malignant glioma	0.000773	0.574	CrCbGaD
Ifosfamide—Infertility—Temozolomide—malignant glioma	0.000752	0.0228	CcSEcCtD
Ifosfamide—Acute leukaemia—Carmustine—malignant glioma	0.000711	0.0216	CcSEcCtD
Ifosfamide—Acute leukaemia—Temozolomide—malignant glioma	0.000687	0.0208	CcSEcCtD
Ifosfamide—Nephrotoxicity—Carmustine—malignant glioma	0.000639	0.0194	CcSEcCtD
Ifosfamide—Skin necrosis—Carmustine—malignant glioma	0.000581	0.0176	CcSEcCtD
Ifosfamide—Cyclophosphamide—CYP2B6—malignant glioma	0.000574	0.426	CrCbGaD
Ifosfamide—Pulmonary fibrosis—Carmustine—malignant glioma	0.000462	0.014	CcSEcCtD
Ifosfamide—Pulmonary fibrosis—Temozolomide—malignant glioma	0.000446	0.0135	CcSEcCtD
Ifosfamide—Myelosuppression—Carmustine—malignant glioma	0.000433	0.0131	CcSEcCtD
Ifosfamide—Myelosuppression—Temozolomide—malignant glioma	0.000418	0.0127	CcSEcCtD
Ifosfamide—Interstitial pneumonia—Temozolomide—malignant glioma	0.000406	0.0123	CcSEcCtD
Ifosfamide—Faecal incontinence—Carmustine—malignant glioma	0.000402	0.0122	CcSEcCtD
Ifosfamide—Faecal incontinence—Temozolomide—malignant glioma	0.000389	0.0118	CcSEcCtD
Ifosfamide—Nephropathy toxic—Carmustine—malignant glioma	0.000354	0.0107	CcSEcCtD
Ifosfamide—Skin hyperpigmentation—Carmustine—malignant glioma	0.000341	0.0104	CcSEcCtD
Ifosfamide—Febrile neutropenia—Carmustine—malignant glioma	0.000338	0.0102	CcSEcCtD
Ifosfamide—Febrile neutropenia—Temozolomide—malignant glioma	0.000326	0.00989	CcSEcCtD
Ifosfamide—Deep vein thrombosis—Temozolomide—malignant glioma	0.000323	0.00978	CcSEcCtD
Ifosfamide—Cyst—Carmustine—malignant glioma	0.000304	0.00921	CcSEcCtD
Ifosfamide—Paranoia—Carmustine—malignant glioma	0.000298	0.00904	CcSEcCtD
Ifosfamide—Interstitial lung disease—Carmustine—malignant glioma	0.000287	0.0087	CcSEcCtD
Ifosfamide—Interstitial lung disease—Temozolomide—malignant glioma	0.000277	0.00841	CcSEcCtD
Ifosfamide—Stupor—Carmustine—malignant glioma	0.000272	0.00825	CcSEcCtD
Ifosfamide—Hepatotoxicity—Carmustine—malignant glioma	0.000263	0.00798	CcSEcCtD
Ifosfamide—Extrapyramidal disorder—Temozolomide—malignant glioma	0.000261	0.0079	CcSEcCtD
Ifosfamide—Herpes zoster—Temozolomide—malignant glioma	0.000261	0.0079	CcSEcCtD
Ifosfamide—Necrosis—Carmustine—malignant glioma	0.000259	0.00785	CcSEcCtD
Ifosfamide—Cholestasis—Temozolomide—malignant glioma	0.000258	0.00784	CcSEcCtD
Ifosfamide—Hepatotoxicity—Temozolomide—malignant glioma	0.000254	0.00771	CcSEcCtD
Ifosfamide—Coagulopathy—Temozolomide—malignant glioma	0.000252	0.00765	CcSEcCtD
Ifosfamide—Petechiae—Temozolomide—malignant glioma	0.000239	0.00724	CcSEcCtD
Ifosfamide—Endocrine disorder—Temozolomide—malignant glioma	0.000237	0.00718	CcSEcCtD
Ifosfamide—Extravasation—Carmustine—malignant glioma	0.000233	0.00706	CcSEcCtD
Ifosfamide—Amenorrhoea—Temozolomide—malignant glioma	0.000223	0.00677	CcSEcCtD
Ifosfamide—Drug interaction—Carmustine—malignant glioma	0.000219	0.00664	CcSEcCtD
Ifosfamide—Gait disturbance—Carmustine—malignant glioma	0.000208	0.00631	CcSEcCtD
Ifosfamide—Hearing impaired—Temozolomide—malignant glioma	0.000206	0.00625	CcSEcCtD
Ifosfamide—Pulmonary embolism—Carmustine—malignant glioma	0.000203	0.00616	CcSEcCtD
Ifosfamide—Gait disturbance—Temozolomide—malignant glioma	0.000201	0.0061	CcSEcCtD
Ifosfamide—Respiratory failure—Temozolomide—malignant glioma	0.0002	0.00606	CcSEcCtD
Ifosfamide—Pulmonary embolism—Temozolomide—malignant glioma	0.000196	0.00595	CcSEcCtD
Ifosfamide—Urinary incontinence—Carmustine—malignant glioma	0.000196	0.00595	CcSEcCtD
Ifosfamide—Depressed level of consciousness—Carmustine—malignant glioma	0.000196	0.00595	CcSEcCtD
Ifosfamide—Skin exfoliation—Carmustine—malignant glioma	0.000194	0.00588	CcSEcCtD
Ifosfamide—Depressed level of consciousness—Temozolomide—malignant glioma	0.000189	0.00575	CcSEcCtD
Ifosfamide—Urinary incontinence—Temozolomide—malignant glioma	0.000189	0.00575	CcSEcCtD
Ifosfamide—Skin exfoliation—Temozolomide—malignant glioma	0.000187	0.00568	CcSEcCtD
Ifosfamide—Coma—Carmustine—malignant glioma	0.000186	0.00563	CcSEcCtD
Ifosfamide—Neoplasm—Carmustine—malignant glioma	0.000184	0.00557	CcSEcCtD
Ifosfamide—Neoplasm—Temozolomide—malignant glioma	0.000177	0.00538	CcSEcCtD
Ifosfamide—Sepsis—Carmustine—malignant glioma	0.000176	0.00535	CcSEcCtD
Ifosfamide—Phlebitis—Carmustine—malignant glioma	0.000171	0.00519	CcSEcCtD
Ifosfamide—Thrombophlebitis—Carmustine—malignant glioma	0.00017	0.00517	CcSEcCtD
Ifosfamide—Swelling—Carmustine—malignant glioma	0.000167	0.00507	CcSEcCtD
Ifosfamide—Thrombophlebitis—Temozolomide—malignant glioma	0.000165	0.00499	CcSEcCtD
Ifosfamide—Deafness—Temozolomide—malignant glioma	0.000159	0.00483	CcSEcCtD
Ifosfamide—Hepatic failure—Temozolomide—malignant glioma	0.000159	0.00481	CcSEcCtD
Ifosfamide—Amnesia—Carmustine—malignant glioma	0.000157	0.00476	CcSEcCtD
Ifosfamide—Amnesia—Temozolomide—malignant glioma	0.000152	0.0046	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000147	0.00447	CcSEcCtD
Ifosfamide—Hypokalaemia—Carmustine—malignant glioma	0.000134	0.00407	CcSEcCtD
Ifosfamide—Hypokalaemia—Temozolomide—malignant glioma	0.00013	0.00393	CcSEcCtD
Ifosfamide—Breast disorder—Temozolomide—malignant glioma	0.000129	0.0039	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000128	0.00389	CcSEcCtD
Ifosfamide—Pancytopenia—Carmustine—malignant glioma	0.000121	0.00367	CcSEcCtD
Ifosfamide—Pancytopenia—Temozolomide—malignant glioma	0.000117	0.00355	CcSEcCtD
Ifosfamide—Dysuria—Temozolomide—malignant glioma	0.000115	0.00349	CcSEcCtD
Ifosfamide—Hyperglycaemia—Carmustine—malignant glioma	0.000115	0.00349	CcSEcCtD
Ifosfamide—Pneumonia—Carmustine—malignant glioma	0.000114	0.00347	CcSEcCtD
Ifosfamide—Pollakiuria—Temozolomide—malignant glioma	0.000114	0.00345	CcSEcCtD
Ifosfamide—Renal failure—Carmustine—malignant glioma	0.000112	0.00339	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Carmustine—malignant glioma	0.000111	0.00338	CcSEcCtD
Ifosfamide—Hyperglycaemia—Temozolomide—malignant glioma	0.000111	0.00337	CcSEcCtD
Ifosfamide—Stomatitis—Carmustine—malignant glioma	0.000111	0.00336	CcSEcCtD
Ifosfamide—Pneumonia—Temozolomide—malignant glioma	0.00011	0.00335	CcSEcCtD
Ifosfamide—Infestation NOS—Temozolomide—malignant glioma	0.00011	0.00333	CcSEcCtD
Ifosfamide—Infestation—Temozolomide—malignant glioma	0.00011	0.00333	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000109	0.0033	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Temozolomide—malignant glioma	0.000108	0.00326	CcSEcCtD
Ifosfamide—Stomatitis—Temozolomide—malignant glioma	0.000107	0.00325	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Temozolomide—malignant glioma	0.000104	0.00315	CcSEcCtD
Ifosfamide—Haemoglobin—Carmustine—malignant glioma	0.000102	0.00311	CcSEcCtD
Ifosfamide—Haemorrhage—Carmustine—malignant glioma	0.000102	0.00309	CcSEcCtD
Ifosfamide—Hallucination—Carmustine—malignant glioma	0.000101	0.00308	CcSEcCtD
Ifosfamide—Connective tissue disorder—Carmustine—malignant glioma	0.0001	0.00304	CcSEcCtD
Ifosfamide—Haemoglobin—Temozolomide—malignant glioma	9.9e-05	0.003	CcSEcCtD
Ifosfamide—Hepatitis—Temozolomide—malignant glioma	9.85e-05	0.00299	CcSEcCtD
Ifosfamide—Haemorrhage—Temozolomide—malignant glioma	9.85e-05	0.00299	CcSEcCtD
Ifosfamide—Visual impairment—Carmustine—malignant glioma	9.83e-05	0.00298	CcSEcCtD
Ifosfamide—Hallucination—Temozolomide—malignant glioma	9.8e-05	0.00297	CcSEcCtD
Ifosfamide—Urinary tract disorder—Temozolomide—malignant glioma	9.73e-05	0.00295	CcSEcCtD
Ifosfamide—Connective tissue disorder—Temozolomide—malignant glioma	9.68e-05	0.00294	CcSEcCtD
Ifosfamide—Urethral disorder—Temozolomide—malignant glioma	9.66e-05	0.00293	CcSEcCtD
Ifosfamide—Eye disorder—Carmustine—malignant glioma	9.53e-05	0.00289	CcSEcCtD
Ifosfamide—Visual impairment—Temozolomide—malignant glioma	9.5e-05	0.00288	CcSEcCtD
Ifosfamide—Flushing—Carmustine—malignant glioma	9.46e-05	0.00287	CcSEcCtD
Ifosfamide—Erythema multiforme—Temozolomide—malignant glioma	9.32e-05	0.00283	CcSEcCtD
Ifosfamide—Eye disorder—Temozolomide—malignant glioma	9.21e-05	0.00279	CcSEcCtD
Ifosfamide—Tinnitus—Temozolomide—malignant glioma	9.19e-05	0.00279	CcSEcCtD
Ifosfamide—Cardiac disorder—Temozolomide—malignant glioma	9.15e-05	0.00277	CcSEcCtD
Ifosfamide—Flushing—Temozolomide—malignant glioma	9.15e-05	0.00277	CcSEcCtD
Ifosfamide—Arrhythmia—Carmustine—malignant glioma	9.11e-05	0.00276	CcSEcCtD
Ifosfamide—Alopecia—Carmustine—malignant glioma	9.01e-05	0.00273	CcSEcCtD
Ifosfamide—Angiopathy—Temozolomide—malignant glioma	8.94e-05	0.00271	CcSEcCtD
Ifosfamide—Mental disorder—Carmustine—malignant glioma	8.93e-05	0.00271	CcSEcCtD
Ifosfamide—Immune system disorder—Temozolomide—malignant glioma	8.9e-05	0.0027	CcSEcCtD
Ifosfamide—Mediastinal disorder—Temozolomide—malignant glioma	8.88e-05	0.00269	CcSEcCtD
Ifosfamide—Malnutrition—Carmustine—malignant glioma	8.88e-05	0.00269	CcSEcCtD
Ifosfamide—Erythema—Carmustine—malignant glioma	8.88e-05	0.00269	CcSEcCtD
Ifosfamide—Chills—Temozolomide—malignant glioma	8.84e-05	0.00268	CcSEcCtD
Ifosfamide—Alopecia—Temozolomide—malignant glioma	8.71e-05	0.00264	CcSEcCtD
Ifosfamide—Mental disorder—Temozolomide—malignant glioma	8.63e-05	0.00262	CcSEcCtD
Ifosfamide—Malnutrition—Temozolomide—malignant glioma	8.58e-05	0.0026	CcSEcCtD
Ifosfamide—Erythema—Temozolomide—malignant glioma	8.58e-05	0.0026	CcSEcCtD
Ifosfamide—Vision blurred—Carmustine—malignant glioma	8.37e-05	0.00254	CcSEcCtD
Ifosfamide—Anaemia—Carmustine—malignant glioma	8.2e-05	0.00249	CcSEcCtD
Ifosfamide—Agitation—Carmustine—malignant glioma	8.16e-05	0.00247	CcSEcCtD
Ifosfamide—Vision blurred—Temozolomide—malignant glioma	8.08e-05	0.00245	CcSEcCtD
Ifosfamide—Ill-defined disorder—Temozolomide—malignant glioma	7.96e-05	0.00241	CcSEcCtD
Ifosfamide—Leukopenia—Carmustine—malignant glioma	7.95e-05	0.00241	CcSEcCtD
Ifosfamide—Anaemia—Temozolomide—malignant glioma	7.93e-05	0.00241	CcSEcCtD
Ifosfamide—Agitation—Temozolomide—malignant glioma	7.88e-05	0.00239	CcSEcCtD
Ifosfamide—Angioedema—Temozolomide—malignant glioma	7.84e-05	0.00238	CcSEcCtD
Ifosfamide—Malaise—Temozolomide—malignant glioma	7.74e-05	0.00235	CcSEcCtD
Ifosfamide—Vertigo—Temozolomide—malignant glioma	7.71e-05	0.00234	CcSEcCtD
Ifosfamide—Convulsion—Carmustine—malignant glioma	7.69e-05	0.00233	CcSEcCtD
Ifosfamide—Leukopenia—Temozolomide—malignant glioma	7.68e-05	0.00233	CcSEcCtD
Ifosfamide—Hypertension—Carmustine—malignant glioma	7.66e-05	0.00232	CcSEcCtD
Ifosfamide—Palpitations—Temozolomide—malignant glioma	7.58e-05	0.0023	CcSEcCtD
Ifosfamide—Myalgia—Carmustine—malignant glioma	7.56e-05	0.00229	CcSEcCtD
Ifosfamide—Chest pain—Carmustine—malignant glioma	7.56e-05	0.00229	CcSEcCtD
Ifosfamide—Cough—Temozolomide—malignant glioma	7.49e-05	0.00227	CcSEcCtD
Ifosfamide—Convulsion—Temozolomide—malignant glioma	7.43e-05	0.00225	CcSEcCtD
Ifosfamide—Hypertension—Temozolomide—malignant glioma	7.41e-05	0.00225	CcSEcCtD
Ifosfamide—Confusional state—Carmustine—malignant glioma	7.3e-05	0.00222	CcSEcCtD
Ifosfamide—Arthralgia—Temozolomide—malignant glioma	7.3e-05	0.00222	CcSEcCtD
Ifosfamide—Myalgia—Temozolomide—malignant glioma	7.3e-05	0.00222	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	7.25e-05	0.0022	CcSEcCtD
Ifosfamide—Oedema—Carmustine—malignant glioma	7.24e-05	0.0022	CcSEcCtD
Ifosfamide—Discomfort—Temozolomide—malignant glioma	7.22e-05	0.00219	CcSEcCtD
Ifosfamide—Infection—Carmustine—malignant glioma	7.2e-05	0.00218	CcSEcCtD
Ifosfamide—Thrombocytopenia—Carmustine—malignant glioma	7.09e-05	0.00215	CcSEcCtD
Ifosfamide—Confusional state—Temozolomide—malignant glioma	7.06e-05	0.00214	CcSEcCtD
Ifosfamide—Anaphylactic shock—Temozolomide—malignant glioma	7e-05	0.00212	CcSEcCtD
Ifosfamide—Oedema—Temozolomide—malignant glioma	7e-05	0.00212	CcSEcCtD
Ifosfamide—Infection—Temozolomide—malignant glioma	6.96e-05	0.00211	CcSEcCtD
Ifosfamide—Anorexia—Carmustine—malignant glioma	6.91e-05	0.00209	CcSEcCtD
Ifosfamide—Nervous system disorder—Temozolomide—malignant glioma	6.87e-05	0.00208	CcSEcCtD
Ifosfamide—Thrombocytopenia—Temozolomide—malignant glioma	6.85e-05	0.00208	CcSEcCtD
Ifosfamide—Skin disorder—Temozolomide—malignant glioma	6.8e-05	0.00206	CcSEcCtD
Ifosfamide—Hypotension—Carmustine—malignant glioma	6.77e-05	0.00205	CcSEcCtD
Ifosfamide—Hyperhidrosis—Temozolomide—malignant glioma	6.77e-05	0.00205	CcSEcCtD
Ifosfamide—Anorexia—Temozolomide—malignant glioma	6.67e-05	0.00202	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Carmustine—malignant glioma	6.6e-05	0.002	CcSEcCtD
Ifosfamide—Paraesthesia—Carmustine—malignant glioma	6.51e-05	0.00197	CcSEcCtD
Ifosfamide—Dyspnoea—Carmustine—malignant glioma	6.46e-05	0.00196	CcSEcCtD
Ifosfamide—Somnolence—Carmustine—malignant glioma	6.44e-05	0.00195	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Temozolomide—malignant glioma	6.38e-05	0.00193	CcSEcCtD
Ifosfamide—Decreased appetite—Carmustine—malignant glioma	6.3e-05	0.00191	CcSEcCtD
Ifosfamide—Paraesthesia—Temozolomide—malignant glioma	6.29e-05	0.00191	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Carmustine—malignant glioma	6.25e-05	0.0019	CcSEcCtD
Ifosfamide—Dyspnoea—Temozolomide—malignant glioma	6.24e-05	0.00189	CcSEcCtD
Ifosfamide—Somnolence—Temozolomide—malignant glioma	6.22e-05	0.00189	CcSEcCtD
Ifosfamide—Pain—Carmustine—malignant glioma	6.2e-05	0.00188	CcSEcCtD
Ifosfamide—Constipation—Carmustine—malignant glioma	6.2e-05	0.00188	CcSEcCtD
Ifosfamide—Decreased appetite—Temozolomide—malignant glioma	6.09e-05	0.00185	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Temozolomide—malignant glioma	6.04e-05	0.00183	CcSEcCtD
Ifosfamide—Fatigue—Temozolomide—malignant glioma	6.04e-05	0.00183	CcSEcCtD
Ifosfamide—Pain—Temozolomide—malignant glioma	5.99e-05	0.00182	CcSEcCtD
Ifosfamide—Constipation—Temozolomide—malignant glioma	5.99e-05	0.00182	CcSEcCtD
Ifosfamide—Feeling abnormal—Carmustine—malignant glioma	5.97e-05	0.00181	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Carmustine—malignant glioma	5.92e-05	0.0018	CcSEcCtD
Ifosfamide—Feeling abnormal—Temozolomide—malignant glioma	5.77e-05	0.00175	CcSEcCtD
Ifosfamide—Abdominal pain—Carmustine—malignant glioma	5.73e-05	0.00174	CcSEcCtD
Ifosfamide—Body temperature increased—Carmustine—malignant glioma	5.73e-05	0.00174	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Temozolomide—malignant glioma	5.72e-05	0.00174	CcSEcCtD
Ifosfamide—Urticaria—Temozolomide—malignant glioma	5.56e-05	0.00169	CcSEcCtD
Ifosfamide—Body temperature increased—Temozolomide—malignant glioma	5.53e-05	0.00168	CcSEcCtD
Ifosfamide—Abdominal pain—Temozolomide—malignant glioma	5.53e-05	0.00168	CcSEcCtD
Ifosfamide—Hypersensitivity—Carmustine—malignant glioma	5.34e-05	0.00162	CcSEcCtD
Ifosfamide—Asthenia—Carmustine—malignant glioma	5.2e-05	0.00158	CcSEcCtD
Ifosfamide—Hypersensitivity—Temozolomide—malignant glioma	5.16e-05	0.00156	CcSEcCtD
Ifosfamide—Asthenia—Temozolomide—malignant glioma	5.02e-05	0.00152	CcSEcCtD
Ifosfamide—Diarrhoea—Carmustine—malignant glioma	4.96e-05	0.0015	CcSEcCtD
Ifosfamide—Pruritus—Temozolomide—malignant glioma	4.95e-05	0.0015	CcSEcCtD
Ifosfamide—Dizziness—Carmustine—malignant glioma	4.79e-05	0.00145	CcSEcCtD
Ifosfamide—Diarrhoea—Temozolomide—malignant glioma	4.79e-05	0.00145	CcSEcCtD
Ifosfamide—Dizziness—Temozolomide—malignant glioma	4.63e-05	0.0014	CcSEcCtD
Ifosfamide—Vomiting—Carmustine—malignant glioma	4.61e-05	0.0014	CcSEcCtD
Ifosfamide—Rash—Carmustine—malignant glioma	4.57e-05	0.00139	CcSEcCtD
Ifosfamide—Dermatitis—Carmustine—malignant glioma	4.56e-05	0.00138	CcSEcCtD
Ifosfamide—Vomiting—Temozolomide—malignant glioma	4.45e-05	0.00135	CcSEcCtD
Ifosfamide—Rash—Temozolomide—malignant glioma	4.41e-05	0.00134	CcSEcCtD
Ifosfamide—Dermatitis—Temozolomide—malignant glioma	4.41e-05	0.00134	CcSEcCtD
Ifosfamide—Nausea—Carmustine—malignant glioma	4.3e-05	0.00131	CcSEcCtD
Ifosfamide—Nausea—Temozolomide—malignant glioma	4.16e-05	0.00126	CcSEcCtD
Ifosfamide—CYP3A5—Metabolism—BCAN—malignant glioma	6.07e-06	0.000332	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	5.99e-06	0.000328	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.87e-06	0.000321	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—COX8A—malignant glioma	5.87e-06	0.000321	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—BCHE—malignant glioma	5.84e-06	0.00032	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP2B6—malignant glioma	5.83e-06	0.000319	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—IDH1—malignant glioma	5.82e-06	0.000318	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—SLC5A5—malignant glioma	5.77e-06	0.000316	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—IDH1—malignant glioma	5.64e-06	0.000308	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SPHK1—malignant glioma	5.63e-06	0.000308	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ASMT—malignant glioma	5.59e-06	0.000306	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP2C18—malignant glioma	5.51e-06	0.000302	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.46e-06	0.000299	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—SPHK1—malignant glioma	5.46e-06	0.000298	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—COX8A—malignant glioma	5.35e-06	0.000292	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP2C18—malignant glioma	5.34e-06	0.000292	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—IDH1—malignant glioma	5.33e-06	0.000292	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—BCAN—malignant glioma	5.25e-06	0.000287	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.24e-06	0.000287	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SPHK1—malignant glioma	5.16e-06	0.000282	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP2C18—malignant glioma	5.05e-06	0.000276	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.04e-06	0.000276	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—IDH2—malignant glioma	5e-06	0.000274	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ASMT—malignant glioma	4.99e-06	0.000273	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—IDH2—malignant glioma	4.89e-06	0.000267	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.87e-06	0.000267	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.78e-06	0.000261	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—BCAN—malignant glioma	4.69e-06	0.000256	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GSTP1—malignant glioma	4.65e-06	0.000254	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP2B6—malignant glioma	4.6e-06	0.000251	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.59e-06	0.000251	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ASMT—malignant glioma	4.55e-06	0.000249	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CAT—malignant glioma	4.52e-06	0.000247	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTT1—malignant glioma	4.46e-06	0.000244	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.44e-06	0.000243	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.43e-06	0.000242	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTT1—malignant glioma	4.32e-06	0.000236	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—IDH1—malignant glioma	4.3e-06	0.000235	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—BCAN—malignant glioma	4.28e-06	0.000234	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NCOR1—malignant glioma	4.27e-06	0.000234	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—IDH2—malignant glioma	4.23e-06	0.000232	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—IDH1—malignant glioma	4.2e-06	0.00023	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS1—malignant glioma	4.18e-06	0.000229	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SPHK1—malignant glioma	4.16e-06	0.000228	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTT1—malignant glioma	4.09e-06	0.000224	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP2C18—malignant glioma	4.08e-06	0.000223	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SPHK1—malignant glioma	4.07e-06	0.000222	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.04e-06	0.000221	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.99e-06	0.000218	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP2C18—malignant glioma	3.99e-06	0.000218	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP2B6—malignant glioma	3.98e-06	0.000218	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—BCHE—malignant glioma	3.88e-06	0.000212	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SLC5A5—malignant glioma	3.84e-06	0.00021	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS1—malignant glioma	3.83e-06	0.000209	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—IDH2—malignant glioma	3.78e-06	0.000207	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—BCHE—malignant glioma	3.77e-06	0.000206	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—SLC5A5—malignant glioma	3.72e-06	0.000203	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—IDH1—malignant glioma	3.64e-06	0.000199	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.56e-06	0.000195	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—BCHE—malignant glioma	3.56e-06	0.000195	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2B6—malignant glioma	3.55e-06	0.000194	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—COX8A—malignant glioma	3.53e-06	0.000193	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SPHK1—malignant glioma	3.52e-06	0.000193	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.52e-06	0.000192	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SLC5A5—malignant glioma	3.52e-06	0.000192	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.49e-06	0.000191	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CAV1—malignant glioma	3.48e-06	0.00019	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP2C18—malignant glioma	3.45e-06	0.000189	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—IDH2—malignant glioma	3.45e-06	0.000188	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTT1—malignant glioma	3.3e-06	0.00018	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.26e-06	0.000178	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—IDH1—malignant glioma	3.25e-06	0.000178	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.25e-06	0.000178	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2B6—malignant glioma	3.24e-06	0.000177	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTT1—malignant glioma	3.22e-06	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CG—malignant glioma	3.17e-06	0.000173	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SPHK1—malignant glioma	3.15e-06	0.000172	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTP1—malignant glioma	3.09e-06	0.000169	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS1—malignant glioma	3.09e-06	0.000169	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2C18—malignant glioma	3.08e-06	0.000169	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PPARG—malignant glioma	3.06e-06	0.000167	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.04e-06	0.000166	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS1—malignant glioma	3.02e-06	0.000165	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CAT—malignant glioma	3.01e-06	0.000164	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ASMT—malignant glioma	3e-06	0.000164	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTP1—malignant glioma	3e-06	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.97e-06	0.000162	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—IDH1—malignant glioma	2.96e-06	0.000162	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CAT—malignant glioma	2.92e-06	0.000159	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.91e-06	0.000159	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—BCHE—malignant glioma	2.87e-06	0.000157	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SPHK1—malignant glioma	2.87e-06	0.000157	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.86e-06	0.000156	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NCOR1—malignant glioma	2.84e-06	0.000155	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SLC5A5—malignant glioma	2.84e-06	0.000155	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTP1—malignant glioma	2.83e-06	0.000155	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—BCAN—malignant glioma	2.82e-06	0.000154	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.81e-06	0.000154	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—BCHE—malignant glioma	2.81e-06	0.000154	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTT1—malignant glioma	2.79e-06	0.000153	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CD—malignant glioma	2.79e-06	0.000153	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SLC5A5—malignant glioma	2.77e-06	0.000152	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CAT—malignant glioma	2.76e-06	0.000151	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NCOR1—malignant glioma	2.75e-06	0.000151	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.65e-06	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.65e-06	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS1—malignant glioma	2.62e-06	0.000143	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.61e-06	0.000143	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NCOR1—malignant glioma	2.6e-06	0.000142	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.55e-06	0.00014	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTT1—malignant glioma	2.49e-06	0.000136	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—BCHE—malignant glioma	2.43e-06	0.000133	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CB—malignant glioma	2.43e-06	0.000133	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.41e-06	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—malignant glioma	2.41e-06	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC5A5—malignant glioma	2.4e-06	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS1—malignant glioma	2.34e-06	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.33e-06	0.000127	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.33e-06	0.000127	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CAV1—malignant glioma	2.32e-06	0.000127	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTP1—malignant glioma	2.29e-06	0.000125	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—IDH2—malignant glioma	2.27e-06	0.000124	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTT1—malignant glioma	2.27e-06	0.000124	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.27e-06	0.000124	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.25e-06	0.000123	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CAV1—malignant glioma	2.24e-06	0.000123	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTP1—malignant glioma	2.23e-06	0.000122	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CAT—malignant glioma	2.22e-06	0.000122	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CAT—malignant glioma	2.17e-06	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—BCHE—malignant glioma	2.17e-06	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.14e-06	0.000117	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.14e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.14e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS1—malignant glioma	2.13e-06	0.000116	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CAV1—malignant glioma	2.12e-06	0.000116	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.12e-06	0.000116	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.11e-06	0.000115	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NCOR1—malignant glioma	2.1e-06	0.000115	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—malignant glioma	2.1e-06	0.000115	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NCOR1—malignant glioma	2.05e-06	0.000112	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—malignant glioma	2.04e-06	0.000112	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARG—malignant glioma	2.04e-06	0.000111	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.03e-06	0.000111	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.01e-06	0.00011	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—BCHE—malignant glioma	1.98e-06	0.000108	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARG—malignant glioma	1.97e-06	0.000108	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.96e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.96e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—IDH1—malignant glioma	1.95e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTP1—malignant glioma	1.94e-06	0.000106	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.93e-06	0.000106	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SPHK1—malignant glioma	1.89e-06	0.000103	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CAT—malignant glioma	1.88e-06	0.000103	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARG—malignant glioma	1.87e-06	0.000102	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CD—malignant glioma	1.85e-06	0.000101	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.85e-06	0.000101	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.85e-06	0.000101	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.83e-06	0.0001	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CD—malignant glioma	1.8e-06	9.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NCOR1—malignant glioma	1.78e-06	9.73e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.75e-06	9.58e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTP1—malignant glioma	1.73e-06	9.45e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CAV1—malignant glioma	1.71e-06	9.36e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.7e-06	9.29e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CAT—malignant glioma	1.68e-06	9.19e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CAV1—malignant glioma	1.67e-06	9.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CB—malignant glioma	1.62e-06	8.84e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—malignant glioma	1.6e-06	8.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.6e-06	8.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NCOR1—malignant glioma	1.59e-06	8.68e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTP1—malignant glioma	1.57e-06	8.61e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CB—malignant glioma	1.57e-06	8.57e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.56e-06	8.53e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—malignant glioma	1.55e-06	8.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CAT—malignant glioma	1.53e-06	8.38e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.52e-06	8.34e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARG—malignant glioma	1.51e-06	8.23e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTT1—malignant glioma	1.5e-06	8.19e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—malignant glioma	1.48e-06	8.1e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CB—malignant glioma	1.48e-06	8.1e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARG—malignant glioma	1.47e-06	8.05e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—malignant glioma	1.47e-06	8.03e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CAV1—malignant glioma	1.45e-06	7.93e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NCOR1—malignant glioma	1.45e-06	7.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS1—malignant glioma	1.4e-06	7.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—malignant glioma	1.4e-06	7.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.39e-06	7.57e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CD—malignant glioma	1.37e-06	7.5e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—malignant glioma	1.35e-06	7.4e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.34e-06	7.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.32e-06	7.22e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—BCHE—malignant glioma	1.31e-06	7.14e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CAV1—malignant glioma	1.29e-06	7.08e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.29e-06	7.05e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—malignant glioma	1.28e-06	7e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARG—malignant glioma	1.27e-06	6.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.24e-06	6.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—malignant glioma	1.21e-06	6.62e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CB—malignant glioma	1.2e-06	6.54e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—malignant glioma	1.18e-06	6.48e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CAV1—malignant glioma	1.18e-06	6.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.18e-06	6.45e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.17e-06	6.39e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.16e-06	6.35e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—malignant glioma	1.16e-06	6.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARG—malignant glioma	1.14e-06	6.22e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.13e-06	6.16e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.07e-06	5.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTP1—malignant glioma	1.04e-06	5.68e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARG—malignant glioma	1.04e-06	5.67e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.04e-06	5.67e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—malignant glioma	1.03e-06	5.65e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.01e-06	5.53e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CAT—malignant glioma	1.01e-06	5.53e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—malignant glioma	1.01e-06	5.52e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—malignant glioma	1e-06	5.48e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—malignant glioma	9.85e-07	5.39e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—malignant glioma	9.55e-07	5.22e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOR1—malignant glioma	9.55e-07	5.22e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CD—malignant glioma	9.45e-07	5.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CB—malignant glioma	9.03e-07	4.94e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—malignant glioma	9.03e-07	4.94e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—malignant glioma	8.95e-07	4.89e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—malignant glioma	8.74e-07	4.78e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CB—malignant glioma	8.23e-07	4.5e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—malignant glioma	8.16e-07	4.46e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—malignant glioma	8.05e-07	4.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—malignant glioma	7.8e-07	4.27e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—malignant glioma	7.8e-07	4.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CAV1—malignant glioma	7.78e-07	4.26e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—malignant glioma	7.38e-07	4.03e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—malignant glioma	7.29e-07	3.98e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—malignant glioma	7.12e-07	3.89e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—malignant glioma	7.12e-07	3.89e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.09e-07	3.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARG—malignant glioma	6.84e-07	3.74e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.23e-07	3.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—malignant glioma	6.17e-07	3.37e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—malignant glioma	5.95e-07	3.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—malignant glioma	5.82e-07	3.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—malignant glioma	5.51e-07	3.01e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.43e-07	2.97e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—malignant glioma	5.38e-07	2.94e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—malignant glioma	5.04e-07	2.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—malignant glioma	5.02e-07	2.75e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—malignant glioma	4.69e-07	2.57e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—malignant glioma	4.5e-07	2.46e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—malignant glioma	4.1e-07	2.24e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.31e-07	1.81e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—malignant glioma	2.7e-07	1.48e-05	CbGpPWpGaD
